Skip to content
healthcare.dev

GUNA-DIUR

NDC 17089-260, amiloride - apis mellifera - berberis vulgaris fruit - hieracium pilosella flowering top - hydrochlorothiazide - solidago virgaurea flowering top - spironolactone - sus scrofa pituitary gland -, solution/ drops, from Guna spa.

Product NDC
17089-260
Status
Listed
Labeler
Guna spa
Dosage form
SOLUTION/ DROPS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17089-260 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMILORIDE4 [hp_X]/30mL
  • APIS MELLIFERA2 [hp_X]/30mL
  • BERBERIS VULGARIS FRUIT.3 g/30mL
  • HYDROCHLOROTHIAZIDE4 [hp_X]/30mL
  • SUS SCROFA PITUITARY GLAND12 [hp_X]/30mL
  • HIERACIUM PILOSELLA FLOWERING TOP.3 g/30mL
  • SOLIDAGO VIRGAUREA FLOWERING TOP.3 g/30mL
  • SPIRONOLACTONE4 [hp_X]/30mL

Pharmacologic classes

Aldosterone Antagonist [EPC]; Aldosterone Antagonists [MoA]; Allergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Increased Diuresis [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Potassium-sparing Diuretic [EPC]; Standardized Insect Venom Allergenic Extract [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
17089-260-18170890260181 BOTTLE, DROPPER in 1 BOX (17089-260-18) / 30 mL in 1 BOTTLE, DROPPER

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17089-260 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17089-260 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17089-260. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.